US Broker Ratings

Elevance Health, Inc. (ELV) Stock Analysis: Navigating Opportunities in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), previously known as Anthem, Inc., is a key player in the healthcare sector with a market capitalization of $90.39 billion. As healthcare continues to be..

Insulet Corporation (PODD) Stock Analysis: Strong Buy Ratings and Nearly 48% Upside Potential

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, particularly within the medical devices industry, stands out with a market capitalization of $11.17 billion. Headquartered in Acton, Massachusetts,..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating Growth Potential and 7.12% Upside

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, is a key player in the pharmaceutical industry with a market capitalization of $305.12 billion. As an investor,..

Novartis AG (NVS) Stock Analysis: Evaluating Its 0.33% Potential Upside Amidst Strong ROE and Dividend Yield

Investors eyeing the healthcare sector often consider Novartis AG (NVS), a Swiss pharmaceutical giant with a market cap of $293.94 billion. As a key player in the drug manufacturing industry,..

Quest Diagnostics (DGX) Stock Analysis: Uncovering a 7.83% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the U.S. healthcare diagnostics and research industry, presents a compelling investment opportunity with its solid fundamentals and promising growth prospects. As a..

HCA Healthcare (HCA) Stock Analysis: Capitalizing on a 21.38% Potential Upside

HCA Healthcare, Inc. (NYSE: HCA) stands as a significant player in the U.S. healthcare sector, boasting a market capitalization of $90.2 billion. As a leading provider of a broad spectrum..

UnitedHealth Group (UNH) Stock Analysis: Evaluating Market Position Amidst Stable Dividend Yield

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, operates primarily within the healthcare plans industry. With a substantial market capitalization of $385.62 billion, UnitedHealth Group stands as..

The Cigna Group (CI) Stock Analysis: Exploring a Potential 16% Upside for Healthcare Investors

The Cigna Group (NYSE: CI) stands as a prominent entity in the healthcare sector, with a robust market capitalization of $77.63 billion. Notably, the company operates in the healthcare plans..

Mettler-Toledo International (MTD) Stock Analysis: Potential Upside and Strategic Positioning in Diagnostics & Research

Mettler-Toledo International Inc. (NYSE: MTD), a prominent player in the diagnostics and research sector, presents a compelling opportunity for investors with its diverse portfolio of precision instruments and a strategic..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Strong Buy Opportunity with 47% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) sits at the forefront of the biotechnology sector, specializing in the groundbreaking field of ribonucleic acid interference (RNAi) therapeutics. With a market capitalization of $39.89..

Stryker Corporation (SYK) Stock Analysis: Unpacking a 17% Potential Upside Amid Robust Market Position

Stryker Corporation (NYSE: SYK) stands as a healthcare titan within the medical devices industry, boasting a formidable market capitalization of $126.42 billion. As a key player in both MedSurg &..

GSK plc (GSK) Stock Analysis: Evaluating the 7.51% Upside Potential in the Healthcare Giant

As one of the stalwarts in the healthcare sector, GSK plc (NYSE: GSK) presents a compelling opportunity for investors looking to capitalize on its strong market position and promising upside..

Sanofi (SNY) Stock Analysis: Discover a Potential 26.56% Upside in the Healthcare Giant

Sanofi (SNY), the Paris-based healthcare titan, stands as a formidable player in the drug manufacturing industry with a market capitalization of $104.13 billion. As an investor focusing on the healthcare..

Danaher Corporation (DHR): Analyst Consensus and Growth Potential with 21.71% Upside

Danaher Corporation (NYSE: DHR), a stalwart in the healthcare sector, is capturing investor attention with its robust potential upside of 21.71%. As a leading player in the diagnostics and research..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Steady Performance with Limited Upside in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a prominent player in the biotechnology sector, continues to capture investor attention with its focus on developing treatments for rare diseases. Headquartered in Redwood City,..

Teleflex Incorporated (TFX) Stock Analysis: Exploring an 8.88% Potential Upside Amid Strong Revenue Growth

Teleflex Incorporated (NYSE: TFX) stands as a formidable player in the healthcare sector, specializing in the medical instruments and supplies industry. With a substantial market cap of $5.93 billion, the..

Bruker Corporation (BRKR) Stock Analysis: Navigating a Complicated Landscape Amidst Healthcare Sector Growth

Bruker Corporation (NASDAQ: BRKR) stands at the forefront of the medical devices industry, operating predominantly within the healthcare sector. Headquartered in Billerica, Massachusetts, the company boasts a market capitalization of..

Inspire Medical Systems (INSP) Stock Analysis: Navigating the Medical Device Market with a 10% Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP) has been a compelling player in the healthcare sector, specifically within the medical devices industry. With a focus on innovative treatments for obstructive sleep..

Elanco Animal Health (ELAN) Stock Analysis: A 19.43% Potential Upside for Investors

Elanco Animal Health Incorporated (NYSE: ELAN) has emerged as a noteworthy player within the healthcare sector, specifically in the drug manufacturing niche for specialty and generic products. Headquartered in Indianapolis,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds